Nalaganje...
Daclizumab Therapy for Multiple Sclerosis
Daclizumab is a humanized monoclonal antibody of IgG1 subtype that binds to the Tac epitope on the interleukin-2 (IL-2) receptor α-chain (CD25), thus, effectively blocking the formation of the high-affinity IL-2 receptor. Because the high-affinity IL-2 receptor signaling promotes expansion of activa...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer-Verlag
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3557356/ https://ncbi.nlm.nih.gov/pubmed/23055048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-012-0147-4 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|